PMAQX
Price
$47.62
Change
+$0.21 (+0.44%)
Updated
Jul 10 closing price
Net Assets
32.07B
PMBCX
Price
$37.23
Change
+$0.16 (+0.43%)
Updated
Jul 10 closing price
Net Assets
32.07B
Interact to see
Advertisement

PMAQX vs PMBCX

Header iconPMAQX vs PMBCX Comparison
Open Charts PMAQX vs PMBCXBanner chart's image
Principal MidCap R6
Price$47.62
Change+$0.21 (+0.44%)
VolumeN/A
Net Assets32.07B
Principal MidCap C
Price$37.23
Change+$0.16 (+0.43%)
VolumeN/A
Net Assets32.07B
PMAQX vs PMBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PMAQX vs. PMBCX commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMAQX is a Buy and PMBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMAQX (32.1B) and PMBCX (32.1B) have equal amount of cash in the bank . PMAQX pays higher dividends than PMBCX: PMAQX (0.19) vs PMBCX (0.00). PMAQX was incepted earlier than PMBCX: PMAQX (9 years) vs PMBCX (18 years). PMBCX (1.75) is less costly to investors than PMAQX (0.59). PMAQX (10.50) and PMBCX (10.50) have comparable annual turnover. PMAQX has a lower initial minimum investment than PMBCX: PMAQX (0) vs PMBCX (1000). PMAQX annual gain was more profitable for investors over the last year : 13.87 vs. PMBCX (11.69). PMAQX return over 5 years is better than : 59.65 vs. PMBCX (45.26).
PMAQXPMBCXPMAQX / PMBCX
Total Expense Ratio0.591.7534%
Annual Report Gross Expense Ratio0.591.7534%
Fund Existence9 years18 years-
Gain YTD6.2295.613111%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets32.1B32.1B100%
Annual Yield % from dividends0.190.00-
Returns for 1 year13.8711.69119%
Returns for 3 years52.3844.24118%
Returns for 5 years59.6545.26132%
Returns for 10 yearsN/A71.94-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNTX0.670.04
+6.03%
Context Therapeutics
SOFI20.970.75
+3.71%
SoFi Technologies
INOD52.700.66
+1.27%
Innodata
RNAC13.54-0.23
-1.67%
Cartesian Therapeutics
ODYS4.77-0.10
-2.07%
Odysight.ai Inc